Intra-individual Comparison of Efficacy and Safety of Metvix(R) Natural Daylight Photodynamic Therapy Versus Conventional Metvix(R) Photodynamic Therapy in Subject With Mild Actinic Keratoses.

Trial Profile

Intra-individual Comparison of Efficacy and Safety of Metvix(R) Natural Daylight Photodynamic Therapy Versus Conventional Metvix(R) Photodynamic Therapy in Subject With Mild Actinic Keratoses.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Acronyms CoMet
  • Sponsors Galderma
  • Most Recent Events

    • 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 20 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top